Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis
dc.contributor.author | Amaral, Andre C. | |
dc.contributor.author | Marques, Alexandre F. | |
dc.contributor.author | Munoz, Julian E. | |
dc.contributor.author | Bocca, Anamelia L. | |
dc.contributor.author | Simioni, Andreza R. | |
dc.contributor.author | Tedesco, Antonio C. | |
dc.contributor.author | Morais, Paulo C. | |
dc.contributor.author | Travassos, Luiz Rodolpho [UNIFESP] | |
dc.contributor.author | Taborda, Carlos Pelleschi [UNIFESP] | |
dc.contributor.author | Felipe, Maria Sueli S. | |
dc.contributor.institution | Universidade de Brasília (UnB) | |
dc.contributor.institution | Univ Catolica Brasilia | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.date.accessioned | 2016-01-24T13:59:21Z | |
dc.date.available | 2016-01-24T13:59:21Z | |
dc.date.issued | 2010-03-01 | |
dc.description.abstract | Background and purpose:The present study reports on the preparation and testing of a sustained delivery system for the immunomodulatory peptide P10 aimed at reducing the in vivo degradation of the peptide and the amount required to elicit a protective immune response against paracoccidioidomycosis.Experimental approach:BALB/c mice were infected with the yeast Paracoccidioides brasiliensis to mimic the chronic form of paracoccidioidomycosis. the animals were treated daily with sulfamethoxazole/trimethoprim alone or combined with peptide P10, either emulsified in Freund's adjuvant or entrapped in poly(lactic acid-glycolic acid) (PLGA) nanoparticles at different concentrations (1 mu g, 5 mu g, 10 mu g, 20 mu g or 40 mu g center dot 50 mu L-1). Therapeutic efficacy was assessed as fungal burden in tissues and the immune response by quantitative determination of cytokines.Key results:Animals given combined chemotherapy and P10 nanotherapy presented a marked reduction of fungal load in the lungs, compared with the non-treated animals. After 30 days of treatment, P10 entrapped within PLGA (1 mu g center dot 50 mu L-1) was more effective than 'free' P10 emulsified in Freund's adjuvant (20 mu g center dot 50 mu L-1), as an adjuvant to chemotherapy. After treatment for 90 days, the higher doses of P10 entrapped within PLGA (5 or 10 mu g center dot 50 mu L-1) were most effective. Treatment with P10 emulsified in Freund's adjuvant (20 mu g center dot 50 mu L-1) or P10 entrapped within PLGA (1 mu g center dot 50 mu L-1) were accompanied by high levels of interferon-gamma in lung.Conclusions and implications:Combination of sulfamethoxazole/trimethoprim with the P10 peptide entrapped within PLGA demonstrated increased therapeutic efficacy against paracoccidioidomycosis. P10 incorporation into PLGA nanoparticles dramatically reduced the peptide amount necessary to elicit a protective effect. | en |
dc.description.affiliation | Univ Brasilia, Dept Biol Celular, Mol Biol Lab, Inst Biol Sci, BR-70910900 Brasilia, DF, Brazil | |
dc.description.affiliation | Univ Brasilia, Inst Phys, BR-70910900 Brasilia, DF, Brazil | |
dc.description.affiliation | Univ Catolica Brasilia, Brasilia, DF, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Chem, BR-14049 Ribeirao Preto, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Biomed Sci, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Med Mycol Lab, LIM53, MTSP, São Paulo, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Microbiol Immunol & Parasitol, São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Microbiol Immunol & Parasitol, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.format.extent | 1126-1132 | |
dc.identifier | http://dx.doi.org/10.1111/j.1476-5381.2009.00617.x | |
dc.identifier.citation | British Journal of Pharmacology. Malden: Wiley-Blackwell Publishing, Inc, v. 159, n. 5, p. 1126-1132, 2010. | |
dc.identifier.doi | 10.1111/j.1476-5381.2009.00617.x | |
dc.identifier.issn | 0007-1188 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/32293 | |
dc.identifier.wos | WOS:000275402000014 | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | British Journal of Pharmacology | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.license | http://olabout.wiley.com/WileyCDA/Section/id-406071.html | |
dc.subject | immunomodulatory peptide | en |
dc.subject | antifungal therapy | en |
dc.subject | biodegradable polymers | en |
dc.subject | drug delivery | en |
dc.subject | nanobiotechnology | en |
dc.title | Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis | en |
dc.type | info:eu-repo/semantics/article |